546 related articles for article (PubMed ID: 12891222)
1. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
[TBL] [Abstract][Full Text] [Related]
2. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.
Farkas D; Oleson LE; Zhao Y; Harmatz JS; Zinny MA; Court MH; Greenblatt DJ
J Clin Pharmacol; 2007 Mar; 47(3):286-94. PubMed ID: 17322140
[TBL] [Abstract][Full Text] [Related]
3. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir.
Culm-Merdek KE; von Moltke LL; Gan L; Horan KA; Reynolds R; Harmatz JS; Court MH; Greenblatt DJ
Clin Pharmacol Ther; 2006 Mar; 79(3):243-54. PubMed ID: 16513448
[TBL] [Abstract][Full Text] [Related]
4. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
5. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
[TBL] [Abstract][Full Text] [Related]
6. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
7. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
[TBL] [Abstract][Full Text] [Related]
8. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Edwards DJ; Bellevue FH; Woster PM
Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
[TBL] [Abstract][Full Text] [Related]
9. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam.
Chaobal HN; Kharasch ED
Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
[TBL] [Abstract][Full Text] [Related]
11. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
12. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.
Hidaka M; Okumura M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Setoguchi N; Arimori K
Drug Metab Dispos; 2005 May; 33(5):644-8. PubMed ID: 15673597
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.
Kuze J; Mutoh T; Takenaka T; Oda N; Hanioka N; Narimatsu S
Xenobiotica; 2013 Jul; 43(7):598-606. PubMed ID: 23282066
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
16. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
Hukkanen J; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
[TBL] [Abstract][Full Text] [Related]
17. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity.
Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y
Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159
[TBL] [Abstract][Full Text] [Related]
18. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
[TBL] [Abstract][Full Text] [Related]
19. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
Kakar SM; Paine MF; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
[TBL] [Abstract][Full Text] [Related]
20. Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics.
Kawaguchi-Suzuki M; Nasiri-Kenari N; Shuster J; Gmitter FG; Cancalon P; de Oliveria F; Kight J; Handberg EM; Pepine CJ; Frye RF; Cooper-DeHoff RM
J Clin Pharmacol; 2017 Mar; 57(3):305-311. PubMed ID: 27503364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
